73
Views
0
CrossRef citations to date
0
Altmetric
Articles

Readmissions after radical nephrectomy in a national cohort

, , , , , & show all
Pages 75-80 | Received 19 Aug 2022, Accepted 02 Jan 2023, Published online: 16 Jan 2023
 

Abstract

Objective

To analyze the factors and costs associated with 30-day readmissions for patients undergoing radical nephrectomy.

Materials and Methods

We used the 2014 Nationwide Readmission Database to identify adults who underwent radical nephrectomy for renal cancer, stratified by surgical approach. We determined patient factors associated with readmission rates, diagnoses, and costs using multivariate logistic regression.

Results

Among 19,523 individuals, the 30-day readmission rate was 7.7% (n = 1,506). On multivariate regression, odds of readmission were significantly increased with age ≥75 in those who underwent open nephrectomy (OR: 1.35; 95%CI: 1.03–1.78). Subjects with a Charlson comorbidity score ≥3 had significantly higher rates of readmission regardless of surgical approach (Open RN – OR: 1.85; 95%CI: 1.33–2.56; Lap RN – OR: 1.99; 95%CI 1.10–3.59; Robotic RN – OR: 2.18; 95%CI: 1.23–3.86). Common reasons for readmission were gastrointestinal, cardiovascular, urinary tract infections, and wound complications across all surgical approaches. The mean cost per readmission was as high as 126% ($20,357) of the mean index admission cost.

Conclusion

One in 13 adults undergoing radical nephrectomy is readmitted within 30 days of discharge. Associated readmission cost is up to 1.26 times the cost of index admission. Our findings may inform efforts aiming to reduce hospital readmissions and curtail healthcare costs.

Acknowledgments

All authors would like to thank the faculty at the David Geffen School of Medicine at UCLA for their continued mentorship and guidance in completing this research project.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.